机构:[1]Chair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany[2]West China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[3]Department of Internal Medicine I, Faculty of Medicine, LMU Munich, Germany[4]Walter Brendel Centre of Experimental Medicine, University Hospital, LMU Munich, Germany[5]German Center for Infection Research (DZIF), LMU Munich, Germany
Helicobacter pylori colonizes half of the global population and causes gastritis, peptic ulcer disease or gastric cancer. In this study, we were interested in human annexin (ANX), which comprises a protein family with diverse and partly unknown physiological functions, but with a potential role in microbial infections and possible involvement in gastric cancer. We demonstrate here for the first time that H. pylori is able to specifically bind ANXs. Binding studies with purified H. pylori LPS and specific H. pylori LPS mutant strains indicated binding of ANXA5 to lipid A, which was dependent on the lipid A phosphorylation status. Remarkably, ANXA5 binding almost completely inhibited LPS-mediated Toll-like receptor 4- (TLR4) signaling in a TLR4-specific reporter cell line. Furthermore, the interaction is relevant for gastric colonization, as a mouse-adapted H. pylori increased its ANXA5 binding capacity after gastric passage and its ANXA5 incubation in vitro interfered with TLR4 signaling. Moreover, both ANXA2 and ANXA5 levels were upregulated in H. pylori-infected human gastric tissue, and H. pylori can be found in close association with ANXs in the human stomach. Furthermore, an inhibitory effect of ANXA5 binding for CagA translocation could be confirmed. Taken together, our results highlight an adaptive ability of H. pylori to interact with the host cell factor ANX potentially dampening innate immune recognition.
基金:
The work was funded by research grants
from the Deutsche Forschungsgemeinschaft
(SFB914, Project B5 and DFG HA2697/16-2 for RH
and SFB914, Project Z01 for HI-A) and by the
Fo¨rderung von Forschung und Lehre (Fo¨FoLe)
Program of the LMU Munich (Reg.-Nr. 54/2014) to
RH and LFJS. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|1 区寄生虫学1 区病毒学1 区微生物学
最新[2023]版:
大类|1 区医学
小类|1 区微生物学1 区寄生虫学1 区病毒学
第一作者:
第一作者机构:[1]Chair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany
共同第一作者:
通讯作者:
通讯机构:[1]Chair of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Germany[5]German Center for Infection Research (DZIF), LMU Munich, Germany
推荐引用方式(GB/T 7714):
Schmidinger Barbara,Petri Kristina,Lettl Clara,et al.Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling.[J].PLoS pathogens.2022,18(2):e1010326.doi:10.1371/journal.ppat.1010326.
APA:
Schmidinger Barbara,Petri Kristina,Lettl Clara,Li Hong,Namineni Sukumar...&Haas Rainer.(2022).Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling..PLoS pathogens,18,(2)
MLA:
Schmidinger Barbara,et al."Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling.".PLoS pathogens 18..2(2022):e1010326